Lisa Delfini

Insider Reports History

Location
New Haven, CT
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Delfini:

Company Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Chief Financial Officer Common Stock 64,660 $33,041 $0.5110 08 Jan 2025 Direct
Trevi Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 225,500 18 Feb 2025 Direct
Trevi Therapeutics, Inc. Chief Financial Officer Performance Stock Option (right to buy) 110,400 31 May 2025 Direct

Insider Reports Filed by Lisa Delfini

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRVI Trevi Therapeutics, Inc. 31 May 2025 1 $0 4 Chief Financial Officer 03 Jun 2025, 16:00
TRVI Trevi Therapeutics, Inc. 10 Mar 2025 1 $0 4 Chief Financial Officer 12 Mar 2025, 16:00
TRVI Trevi Therapeutics, Inc. 18 Feb 2025 1 $0 4 Chief Financial Officer 20 Feb 2025, 16:00
TRVI Trevi Therapeutics, Inc. 07 Jan 2025 4 +$3,066 4 Chief Financial Officer 10 Jan 2025, 16:14
TRVI Trevi Therapeutics, Inc. 22 May 2024 3 -$3,287 4 Chief Financial Officer 24 May 2024, 16:12
TRVI Trevi Therapeutics, Inc. 15 Feb 2024 1 $0 4 Chief Financial Officer 16 Feb 2024, 16:42
TRVI Trevi Therapeutics, Inc. 11 Oct 2023 3 -$414 4 Chief Financial Officer 12 Oct 2023, 16:00
TRVI Trevi Therapeutics, Inc. 11 Sep 2023 3 -$393 4 Chief Financial Officer 13 Sep 2023, 16:06
TRVI Trevi Therapeutics, Inc. 11 Aug 2023 3 -$438 4 Chief Financial Officer 14 Aug 2023, 16:00
TRVI Trevi Therapeutics, Inc. 11 Jul 2023 3 -$436 4 Chief Financial Officer 12 Jul 2023, 16:29
TRVI Trevi Therapeutics, Inc. 12 Jun 2023 3 -$440 4 Chief Financial Officer 14 Jun 2023, 16:28
TRVI Trevi Therapeutics, Inc. 11 May 2023 3 -$453 4 Chief Financial Officer 15 May 2023, 16:00
TRVI Trevi Therapeutics, Inc. 11 Apr 2023 3 -$374 4 Chief Financial Officer 12 Apr 2023, 17:02
TRVI Trevi Therapeutics, Inc. 13 Mar 2023 3 -$393 4 Chief Financial Officer 15 Mar 2023, 16:00
TRVI Trevi Therapeutics, Inc. 16 Feb 2023 1 $0 4 Chief Financial Officer 16 Feb 2023, 16:18
TRVI Trevi Therapeutics, Inc. 13 Feb 2023 3 -$6,709 4 Chief Financial Officer 15 Feb 2023, 15:01
TRVI Trevi Therapeutics, Inc. 11 Feb 2022 1 $0 4 Chief Financial Officer 15 Feb 2022, 15:00
TRVI Trevi Therapeutics, Inc. 09 Aug 2021 1 $0 4 Chief Financial Officer 09 Aug 2021, 17:34
TRVI Trevi Therapeutics, Inc. 09 Aug 2021 0 $0 3 Chief Financial Officer 09 Aug 2021, 17:29